Comparison of Outcomes After Laparoscopic Versus Open Appendectomy in Acute Appendicitis
NCT ID: NCT03947372
Last Updated: 2019-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
116 participants
INTERVENTIONAL
2015-02-21
2015-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Appendectomy by Multi-port vs Single Port.
NCT01720082
Laparoscopic Cholecystectomy in Management of ACC Within Versus After 3 Days
NCT03477253
Early Versus Interval Laparoscopic Cholecystectomy for Acute Cholecystitis
NCT07021300
Comparison of Frequency of Wound Infection Between Open and Laparoscopic Cholecystectomy
NCT07103707
Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.
NCT05366907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Open appendicectomy has been a safe and usually opted mode of operation for acute appendicitis for more than a century, but since last 10 years laparoscopic appendicectomy is gaining popularity, although still not as popular as laparoscopic cholecystectomy. Comparison of these two is studied in terms of pain outcome as patient perceives and length of hospital stay.
OBJECTIVES:
The objective of this study was to compare the outcome of open appendectomy and laparoscopic appendectomy in patients with acute appendicitis.
STUDY DESIGN: Randomized control trial
SETTING:
Surgical Unit I, Services Hospital, Lahore
DURATION OF STUDY:
Duration of my study was six months after the approval of synopsis i.e 21-02-2015 to 20-08-2015.
SAMPLE SIZE:
Was calculated using WHO method of calculating sample size.
SAMPLING TECHNIQUE:
Non probability consecutive sampling.
DATA COLLECTION PROCEDURE:
All patients fulfilled the inclusion criteria was admitted through the emergency after taking approval from hospital Ethical committee. A detailed history had been taken including demographic data (age, address). Patients was requested to sign an informed consent. They had been assured regarding confidentiality and expertise used for the procedure. All procedures was done by a single operating surgical team to control bias. All the data/variables was recorded on a specially designed Performa attached which are post-op pain at 12hrs and 24 hrs, post-Op stay and patient satisfaction score.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OA (open Appendectomy)
Open Appendectomy
Appendectomy
removal of acutely inflamed appendix
LA (Laparoscopic Appendectomy)
Laparoscopic Appendectomy
Appendectomy
removal of acutely inflamed appendix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Appendectomy
removal of acutely inflamed appendix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Palpable mass in the right lower quadrant as assessed by clinical exam.
* History of Co-morbidities e.g. known diabetic, known hypertensive, cirrhosis as shown by ultrasonography and coagulation disorder (to be determined by low platelet count; \<140 \*109, deranged PT and APTT).(PT=13sec, APTT= 33 sec)
* Patients unfit for surgery (ASA Grade III/IV).
* Patient who did not give informed consent.
15 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Services Hospital, Lahore
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Safia Zahir Ahmed
principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
services Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB/451/SIMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.